ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,132
Screening encounters
4,910
Diagnostic referrals
935
Outstanding pathways
324

Screening pathway

  1. Screening4,910Encounters
  2. Positive finding1,695Documented findings
  3. Referral935Diagnostic referrals
  4. Follow-up1,117Diagnostic visits
  5. Outcome611Resolved pathways

Stage totals use different units. Pending pathways: 324. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0652 · EXP-0652Synthetic · Site A

Full participant history through 2027-01-11, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-08-17
  4. · Diagnostic referral · EXP-0652-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Navigation intervention · Coordination support
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-05
  16. · Follow-up disposition · Resolved · EXP-0652-T-R
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate
  19. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  20. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4132 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1767 · Expanded synthetic participant 1767Site A — Urban Referral Hub
EXP-1768 · Expanded synthetic participant 1768Site A — Urban Referral Hub
EXP-1770 · Expanded synthetic participant 1770Site C — Rural Outreach Programme
EXP-1771 · Expanded synthetic participant 1771Site B — Peri-Urban Access Programme
EXP-1773 · Expanded synthetic participant 1773Site B — Peri-Urban Access Programme
EXP-1774 · Expanded synthetic participant 1774Site D — Community Engagement Programme
EXP-1775 · Expanded synthetic participant 1775Site B — Peri-Urban Access Programme
EXP-1776 · Expanded synthetic participant 1776Site A — Urban Referral Hub
EXP-1777 · Expanded synthetic participant 1777Site D — Community Engagement Programme
EXP-1778 · Expanded synthetic participant 1778Site B — Peri-Urban Access Programme
EXP-1779 · Expanded synthetic participant 1779Site B — Peri-Urban Access Programme
EXP-1780 · Expanded synthetic participant 1780Site C — Rural Outreach Programme
EXP-1781 · Expanded synthetic participant 1781Site B — Peri-Urban Access Programme
EXP-1785 · Expanded synthetic participant 1785Site D — Community Engagement Programme
EXP-1786 · Expanded synthetic participant 1786Site D — Community Engagement Programme
EXP-1789 · Expanded synthetic participant 1789Site E — Resource-Constrained Navigation Programme
EXP-1791 · Expanded synthetic participant 1791Site B — Peri-Urban Access Programme
EXP-1792 · Expanded synthetic participant 1792Site B — Peri-Urban Access Programme
EXP-1793 · Expanded synthetic participant 1793Site B — Peri-Urban Access Programme
EXP-1796 · Expanded synthetic participant 1796Site C — Rural Outreach Programme
EXP-1797 · Expanded synthetic participant 1797Site E — Resource-Constrained Navigation Programme
EXP-1798 · Expanded synthetic participant 1798Site A — Urban Referral Hub
EXP-1799 · Expanded synthetic participant 1799Site C — Rural Outreach Programme
EXP-1801 · Expanded synthetic participant 1801Site A — Urban Referral Hub
EXP-1802 · Expanded synthetic participant 1802Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1866
HPV DNA
2356
Cytology
688

Navigation activity

Barrier documented
836
Contact attempt
1363
Navigation intervention
367
Diagnostic booking
1160
Diagnostic visit
1117

Documented barriers

Contact difficulty
266
Transport difficulty
277
Appointment coordination
293

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.